Long-term Safety of Idebenone in Patients With Leber Hereditary Optic Neuropathy With Alcohol or Tobacco Use/Abuse or Vitamin B12 Deficiency: Results From the PAROS Study (AAN 2026) - Mar 6, 2026 - Abstract #17-006; Pres time: Apr 22, 2026; 08:00 AM - 09:00 AM; Location: McCormick Place West | Hall F; In-Person; Virtual; P=N/A | "Conclusions Long-term idebenone treatment was well-tolerated overall and in the Alc/Tob and VitB12 subpopulations, with no unexpected safety findings observed in a real-world clinical setting. Results were consistent with the known safety profile of idebenone."
Clinical • Inherited Retinal Dystrophy • Leber Hereditary Optic Neuropathy • Metabolic Disorders • Ocular Inflammation • Ophthalmology • Optic Neuritis • Pain • Tobacco Addiction
|
|
Nancy Newman1; Berthold Pemp2; Thomas Klopstock3; Xavier Llòria4; Valerio Carelli5
|